Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5EE7

Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893

5EE7 の概要
エントリーDOI10.2210/pdb5ee7/pdb
分子名称Glucagon receptor,Endolysin,Glucagon receptor, 3-[[4-[(1~{S})-1-[3-[3,5-bis(chloranyl)phenyl]-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]phenyl]carbonylamino]propanoic acid, OLEIC ACID, ... (6 entities in total)
機能のキーワードgpcr, signaling protein, 7tm
由来する生物種Homo sapiens (Human)
詳細
細胞内の位置Cell membrane ; Multi-pass membrane protein : P47871
タンパク質・核酸の鎖数1
化学式量合計56370.97
構造登録者
主引用文献Jazayeri, A.,Dore, A.S.,Lamb, D.,Krishnamurthy, H.,Southall, S.M.,Baig, A.H.,Bortolato, A.,Koglin, M.,Robertson, N.J.,Errey, J.C.,Andrews, S.P.,Teobald, I.,Brown, A.J.,Cooke, R.M.,Weir, M.,Marshall, F.H.
Extra-helical binding site of a glucagon receptor antagonist.
Nature, 533:274-277, 2016
Cited by
PubMed Abstract: Glucagon is a 29-amino-acid peptide released from the α-cells of the islet of Langerhans, which has a key role in glucose homeostasis. Glucagon action is transduced by the class B G-protein-coupled glucagon receptor (GCGR), which is located on liver, kidney, intestinal smooth muscle, brain, adipose tissue, heart and pancreas cells, and this receptor has been considered an important drug target in the treatment of diabetes. Administration of recently identified small-molecule GCGR antagonists in patients with type 2 diabetes results in a substantial reduction of fasting and postprandial glucose concentrations. Although an X-ray structure of the transmembrane domain of the GCGR has previously been solved, the ligand (NNC0640) was not resolved. Here we report the 2.5 Å structure of human GCGR in complex with the antagonist MK-0893 (ref. 4), which is found to bind to an allosteric site outside the seven transmembrane (7TM) helical bundle in a position between TM6 and TM7 extending into the lipid bilayer. Mutagenesis of key residues identified in the X-ray structure confirms their role in the binding of MK-0893 to the receptor. The unexpected position of the binding site for MK-0893, which is structurally similar to other GCGR antagonists, suggests that glucagon activation of the receptor is prevented by restriction of the outward helical movement of TM6 required for G-protein coupling. Structural knowledge of class B receptors is limited, with only one other ligand-binding site defined--for the corticotropin-releasing hormone receptor 1 (CRF1R)--which was located deep within the 7TM bundle. We describe a completely novel allosteric binding site for class B receptors, providing an opportunity for structure-based drug design for this receptor class and furthering our understanding of the mechanisms of activation of these receptors.
PubMed: 27111510
DOI: 10.1038/nature17414
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.5 Å)
構造検証レポート
Validation report summary of 5ee7
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon